Pharming Group N.V.
PHGUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,492 | -$9,554 | $14,987 | $22,032 |
| Dep. & Amort. | $16,070 | $15,925 | $13,188 | $18,721 |
| Deferred Tax | $0 | $0 | $0 | -$721 |
| Stock-Based Comp. | $11,248 | $9,251 | $6,392 | $9,056 |
| Change in WC | -$10,072 | -$16,961 | -$387 | -$4,735 |
| Other Non-Cash | -$10,549 | -$15,963 | -$11,283 | -$7,817 |
| Operating Cash Flow | -$1,795 | -$17,302 | $22,897 | $36,126 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$762 | -$1,464 | -$1,977 | -$15,958 |
| Net Acquisitions | $0 | $0 | $7,300 | $0 |
| Inv. Purchases | -$284,314 | -$382,014 | $0 | -$4,381 |
| Inv. Sales/Matur. | $316,728 | $232,811 | $0 | $0 |
| Other Inv. Act. | -$34 | $21,279 | $6,256 | -$0 |
| Investing Cash Flow | $31,618 | -$129,388 | $5,323 | -$20,338 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$34,393 | -$4,643 | -$3,092 | -$2,826 |
| Stock Issued | $5,339 | $0 | $2,281 | $4,718 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5,358 | $3,702 | -$4,171 | -$29,839 |
| Financing Cash Flow | -$34,412 | -$941 | -$4,982 | -$26,679 |
| Forex Effect | -$2,208 | $1,928 | -$7,820 | $13,458 |
| Net Chg. in Cash | -$6,797 | -$145,601 | $15,418 | $2,567 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $61,741 | $207,342 | $191,924 | $189,158 |
| End Cash | $54,944 | $61,741 | $207,342 | $191,725 |
| Free Cash Flow | -$6,723 | -$18,766 | $20,920 | $20,168 |